Cover Image
市場調查報告書

心臟心律調節器設備的全球市場:市場機會分析、產業預測

Cardiac Pacemaker Devices Market - Global Opportunity Analysis and Industry Forecast (2017-2022)

出版商 Meticulous Market Research Pvt. Ltd. 商品編碼 600664
出版日期 內容資訊 英文 163 Pages
訂單完成後即時交付
價格
Back to Top
心臟心律調節器設備的全球市場:市場機會分析、產業預測 Cardiac Pacemaker Devices Market - Global Opportunity Analysis and Industry Forecast (2017-2022)
出版日期: 2018年01月23日 內容資訊: 英文 163 Pages
簡介

本報告提供全球心臟心律調節器設備的市場調查,市場及產品概要,市場成長的各種影響因素及市場機會分析,相關法律,各產品類型、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭情形,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場考察

  • 簡介
  • 市場成長促進因素
  • 市場成長阻礙因素
  • 市場機會
  • 課題
  • 法律規章分析:各地區
  • 企業佔有率分析

第5章 市場分析、預測: 各產品類型

  • 簡介
  • 心臟心律調節器
    • 植入式心律調節器
      • 單室
      • 雙心腔型
    • 外置心律調節器
  • 起搏器電極線
  • 起搏分析儀

第6章 市場分析、預測:各終端用戶

  • 簡介
  • 醫院
  • 門診外科中心
  • 其他

第7章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區
    • 南美
    • 中東、非洲

第8章 競爭環境

  • 核准
  • 新產品的投入
  • 聯盟、協定、合作
  • M&A
  • 擴張

第9章 企業簡介

  • Medtronic PLC
  • Boston Scientific Corporation
  • Biotronik SE & Co., KG
  • LivaNova PLC
  • Abbott Laboratories
  • Medico S.P.A.
  • Shree Pacetronix Ltd.
  • Osypka Medical GmbH
  • Lepu Medical Group
  • Cook Group

第10章 附錄

目錄
Product Code: MRMD-10440

>Cardiac Pacemaker Devices Market Size by Product (Implantable Cardiac Pacemaker, External Pacemaker, Pacing Leads, and Pacing Analyzer), End-User (Hospitals and Ambulatory Surgery Centers) - Global Opportunity Analysis and Industry Forecast (2017-2022)

The arena of cardiovascular medicine is swiftly evolving as advancements in technology and engineering offer clinicians' new and exhilarating ways to care for an aging population. Cardiac pacing, in particular, has witnessed a series of game-changing technologies emerging since the past several years spurred by low-power electronics, high-density batteries, improved catheter delivery systems, and innovative software designs. The cardiac pacemaker devices can control & restore the human heart's normal electrical pathways and thereby helps to avoid severe life-threatening cardiovascular arrest in the patients at high risk. Therefore, the adoption of these devices is rising with technological innovation and rising incidence & prevalence of chronic cardiovascular diseases and related death globally. For instance, according to the American Heart Association, cardiovascular disease is the leading cause of death globally, accounting for more than 17.3 million deaths in 2013. This number is estimated to grow to more than 23.6 million by 2030.

Global cardiac pacemaker devices market is expected to grow at a CAGR of 3.3% from 2017 to 2022 to reach USD 4,629.3 million by 2022. Following an extensive secondary and primary research on cardiac rhythm management devices including cardiac pacemakers and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, challenges, opportunities, and key trends in this market. Increasing burden of cardiovascular diseases, rising geriatric population, rise in obesity, sedentary lifestyle, excessive consumption of alcohol & caffeinated products, and various technological advancements are the key market drivers covered in the report which will support the industry growth in the forecast period. However, increase in reported cases of cardiac pacemaker malfunctioning & related product recalls restricts the growth of the market to some extent. Further, lack of skilled professionals, especially cardiologists poses great challenge for the growth of this market.

The global cardiac pacemaker devices market studied in the report is majorly segmented by product (cardiac pacemakers, pacing leads, and pacing analyzer), end user (hospitals, ambulatory surgery centers, and others), and geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa). The report further provides the details on each segment and sub-segment of various products. For instance, the report briefly talks about the dynamics of the various products categories including implantable pacemakers (single-chamber and dual-chamber), external pacemakers, pacing leads, and pacing analyzers. Each segment further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use these products in high risk cardiovascular diseases to improve overall treatment.

An exhaustive geographic analysis of the industry covering five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa is included in the geographic analysis section. These regions are further analysed at a country level with the detailed qualitative and quantitative analysis. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The geographic analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

image1

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017). The study has also incorporated the market share analysis of leading players and detailed profiles of top 10 market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.

The key players operating in the global cardiac pacemaker devices market are Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Lepu Medical Technology Co ltd (China), Medico, S.p.A (Italy), Osypka Medical GmbH (Germany), Shree Pacetronix Ltd. (India), and Cook Medical Group (U.S.).

Scope of the Report:

Market by Product:

  • Cardiac pacemakers
    • Implantable cardiac pacemaker
      • Single chamber cardiac pacemaker
      • Dual-chamber cardiac pacemaker
    • External pacemaker
  • Pacing leads
  • Pacing analyzers

Market by End-user:

  • Hospitals
  • Ambulatory surgery centers
  • Others

Market by Geography:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • Middle East &Africa

Table of Contents

1. Introduction

  • 1.1. Market Ecosystem
  • 1.2. Currency And Limitations
    • 1.2.1. Currency
    • 1.2.2. Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Secondary Research
    • 2.1.2. Primary Research
    • 2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Rising Geriatric Population
    • 4.2.2. Increasing Burden of Cardiovascular Diseases
    • 4.2.3. Rise in Obesity, Sedentary Lifestyle, & Excessive Consumption of Alcohol & Caffeinated Products
    • 4.2.4. Technological Advancements
    • 4.2.5. Other Drivers
  • 4.3. Restraints
    • 4.3.1. Increase in Reported Cases of Cardiac Pacemaker Malfunction & Product Recalls
    • 4.3.2. Other Restraints
  • 4.4. Opportunities
    • 4.4.1. Emerging Markets Offer Significant Growth Opportunities
    • 4.4.2. Other Opportunities
  • 4.5. Challenges
    • 4.5.1. Lack of Skilled Professionals
    • 4.5.2. Other Challenges
  • 4.6. Regulatory Analysis
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. Rest of World
  • 4.7. Market Share Analysis, by Key Players

5. Cardiac Pacemaker Devices Market, by Product Type

  • 5.1. Introduction
  • 5.2. Cardiac Pacemakers
    • 5.2.1. Implantable Pacemakers
      • 5.2.1.1. Single-Chamber Pacemakers
      • 5.2.1.2. Dual-Chamber Pacemakers
    • 5.2.2. External Pacemakers
  • 5.3. Pacing Leads
  • 5.4. Pacing Analyzers

6. Cardiac Pacemaker Devices Market, by End-User

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Ambulatory Surgery Centers
  • 6.4. Others

7. Cardiac Pacemaker Devices Market, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Rest of Europe (RoE)
  • 7.4. Asia-Pacific
    • 7.4.1. Japan
    • 7.4.2. China
    • 7.4.3. India
    • 7.4.4. RoAPAC
  • 7.5. Rest of the World (RoW)
    • 7.5.1. Latin America
    • 7.5.2. Middle East & Africa

8. Competitive Landscape

  • 8.1. Approvals
  • 8.1. New Product Launches
  • 8.2. Partnerships, Agreements, and Collaborations
  • 8.3. Mergers & Acquisitions
  • 8.4. Expansions

9. Company Profiles

  • 9.1. Medtronic PLC
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product Portfolio
    • 9.1.4. Recent Developments
  • 9.2. Boston Scientific Corporation
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product Portfolio
    • 9.2.4. Recent Developments
  • 9.3. Biotronik SE & Co., KG
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product Portfolio
    • 9.3.4. Recent Developments
  • 9.4. LivaNova PLC
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product Portfolio
    • 9.4.4. Recent Developments
  • 9.5. Abbott Laboratories
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product Portfolio
    • 9.5.4. Recent Developments
  • 9.6. Medico S.P.A.
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product Portfolio
    • 9.6.4. Recent Developments
  • 9.7. Shree Pacetronix Ltd.
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product Portfolio
    • 9.7.4. Recent Developments
  • 9.8. Osypka Medical GmbH
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product Portfolio
    • 9.8.4. Recent Developments
  • 9.9. Lepu Medical Group
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product Portfolio
    • 9.9.4. Recent Developments
  • 9.10. Cook Group
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product Portfolio
    • 9.10.4. Recent Developments

10. Appendix

  • 10.1. Questionnaire
  • 10.2. Available Customization

List of Tables

  • Table 1 Cardiac Pacemaker Devices Market Drivers: Impact Analysis (2017-2022)
  • Table 2 List of Innovative Cardiac Pacemakers Launched Recently With Enhaced Features
  • Table 3 Cardiac Pacemaker Devices Market Restraint: Impact Analysis (2017-2022)
  • Table 4 Number of Cardiac Implant Recalls & Total Recall Reports, 2004-2014
  • Table 5 Global Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 6 Global Cardiac Pacemaker Devices Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 7 Global Cardiac Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 8 Global Cardiac Pacemakers Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 9 Global Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 10 Global Implantable Pacemakers Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 11 Global Single-Chamber Cardiac Pacemakers Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 12 Global Dual-Chamber Cardiac Pacemakers Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 13 Global External Pacemakers Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 14 Global Pacing Leads Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 15 Global Pacing Analyzer Market Size, by Country/ Region, 2015-2022 (USD Million)
  • Table 16 Global Cardiac Pacemaker Devices Market Size, by End-User, 2015-2022 (USD Million)
  • Table 17 Reimbursement Prospectus for Hospital Outpatient Procedure in the U.S.
  • Table 18 U.S. National Medicare Hospital Outpatient Payment Rates for Medtronic Therapies
  • Table 19 Global Cardiac Pacemaker Devices Market Size for Hospitals, by Country/ Region, 2015-2022 (USD Million)
  • Table 20 Changes in Ambulatory Surgery Center Reimbursement Fee Schedule in The U.S., 2016-2017
  • Table 21 Reimbursement Prospectus of Ambulatory Surgical Center in the U.S. by Procedure
  • Table 22 Global Cardiac Pacemaker Devices Market Size for Ambulatory Surgery Centers, by Country/ Region, 2015-2022 (USD Million)
  • Table 23 Cardiac Pacemaker Devices Market Size, for Other End Users, by Country/ Region, 2015-2022 (USD Million)
  • Table 24 Global Cardiac Pacemaker Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 25 North America: Cardiac Pacemaker Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 26 North America: Market Size, by Product, 2015-2022 (USD Million)
  • Table 27 North America: Market Size, by Type, 2015-2022 (USD Million)
  • Table 28 North America: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 29 North America: Market Size, by End-User, 2015-2022 (USD Million)
  • Table 30 U.S.: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 31 U.S.: Market Size, by Type, 2015-2022 (USD Million)
  • Table 32 U.S.: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 33 U.S.: Market Size, by End-Users, 2015-2022 (USD Million)
  • Table 34 Canada: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 35 Canada: Market Size, by Type, 2015-2022 (USD Million)
  • Table 36 Canada: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 37 Canada: Market Size, by End-User, 2015-2022 (USD Million)
  • Table 38 Europe: Cardiac Pacemaker Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 39 Europe: Market Size, by Product, 2015-2022 (USD Million)
  • Table 40 Europe: Market Size, by Type, 2015-2022 (USD Million)
  • Table 41 Europe: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 42 Europe: Market Size, by End-Users, 2015-2022 (USD Million)
  • Table 43 Germany: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 44 Germany: Market Size, by Type, 2015-2022 (USD Million)
  • Table 45 Germany: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 46 Germany: Market Size, by End-User, 2015-2022 (USD Million)
  • Table 47 France: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 48 France: Market Size, by Type, 2015-2022 (USD Million)
  • Table 49 France: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 50 France: Market Size, by End-Users, 2015-2022 (USD Million)
  • Table 51 U.K.: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 52 U.K.: Market Size, by Type, 2015-2022 (USD Million)
  • Table 53 U.K.: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 54 U.K.: Market Size, by End-Users, 2015-2022 (USD Million)
  • Table 55 Italy: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 56 Italy: Market Size, by Type, 2015-2022 (USD Million)
  • Table 57 Italy: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 58 Italy: Market Size, by End-Users, 2015-2022 (USD Million)
  • Table 59 Spain: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 60 Spain: Market Size, by Type, 2015-2022 (USD Million)
  • Table 61 Spain: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 62 Spain: Market Size, by End-Users, 2015-2022 (USD Million)
  • Table 63 RoE: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 64 RoE: Market Size, by Type, 2015-2022 (USD Million)
  • Table 65 RoE: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 66 RoE: Market Size, by End-Users, 2015-2022 (USD Million)
  • Table 67 APAC: Cardiac Pacemaker Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 68 APAC: Market Size, by Product, 2015-2022 (USD Million)
  • Table 69 APAC: Market Size, by Type, 2015-2022 (USD Million)
  • Table 70 APAC: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 71 APAC: Market Size, by End-User, 2015-2022 (USD Million)
  • Table 72 Japan: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 73 Japan:Market Size, by Type, 2015-2022 (USD Million)
  • Table 74 Japan: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 75 Japan:Market Size, by End-User, 2015-2022 (USD Million)
  • Table 76 China: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 77 China: Market Size, by Type, 2015-2022 (USD Million)
  • Table 78 China: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 79 China: Market Size, by End-User, 2015-2022 (USD Million)
  • Table 80 India: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 81 India: Market Size, by Type, 2015-2022 (USD Million)
  • Table 82 India: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 83 India: Market Size, by End-User, 2015-2022 (USD Million)
  • Table 84 RoAPAC: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 85 RoAPAC:Market Size, by Type, 2015-2022 (USD Million)
  • Table 86 RoAPAC: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 87 RoAPAC:Market Size, by End-User, 2015-2022 (USD Million)
  • Table 88 RoW: Cardiac Pacemaker Devices Market Size, by Country, 2015-2022 (USD Million)
  • Table 89 RoW: Market Size, by Product, 2015-2022 (USD Million)
  • Table 90 RoW: Market Size, by Type, 2015-2022 (USD Million)
  • Table 91 RoW: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 92 RoW: Market Size, by End-Users, 2015-2022 (USD Million)
  • Table 93 Latin America: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 94 Latin America: Market Size, by Type, 2015-2022 (USD Million)
  • Table 95 Latin America: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 96 Latin America: Market Size, by End-User, 2015-2022 (USD Million)
  • Table 97 Middle East & Africa: Cardiac Pacemaker Devices Market Size, by Product, 2015-2022 (USD Million)
  • Table 98 Middle East & Africa: Market Size, by Type, 2015-2022 (USD Million)
  • Table 99 Middle East & Africa: Implantable Pacemakers Market Size, by Type, 2015-2022 (USD Million)
  • Table 100 Middle East & Africa: Market Size, by End-User, 2015-2022 (USD Million)
  • Table 101 Number of Developments by the Profiled Companies, 2014-2017
  • Table 102 Approvals
  • Table 103 New Product Launches
  • Table 104 Partnerships, Agreements, and Collaborations
  • Table 105 Mergers & Acquisitions
  • Table 106 Expansions

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Executives Interviewed
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Opportunities
  • Figure 5 Cardiac Pacemaker is the Largest Segment Among all Cardiac Pacemaker Devices
  • Figure 6 Global Cardiac Pacemakers Market Size, by Type, 2017-2022 (USD Million)
  • Figure 7 Dual-Chamber Cardiac Pacemaker Dominates the Single-Chamber Cardiac Pacemaker Market
  • Figure 8 Cardiac Pacemaker Devices Market Size, by End-User, 2017-2022 (USD Million)
  • Figure 9 Global Cardiac Pacemaker Devices Market Overview-2017-2022
  • Figure 10 Key Growth Strategies Adopted by Leading Players -2014-2017
  • Figure 11 Market Dynamics
  • Figure 12 Share of Geriatric Population 60 Years & Above, by Region, 2010-2020
  • Figure 13 Percentage Distribution of Population Aged 65 and Over by Region, 2015-2050
  • Figure 14 Global Cardiovascular Diseases Deaths by Type, 2015
  • Figure 15 Facts About Sudden Cardiac Arrest
  • Figure 16 Risk of Dying From Alcohol Attributed Cause in European Region, 2016
  • Figure 17 Ratio of Total Number of Cardiac Implants Recalls, 2015
  • Figure 18 Percentage Distribution of Population Aged 65 and Over by Region, 2015-2050
  • Figure 19 Total Physician Shortage in the U.S., 2015-2030
  • Figure 20 Regulatory Approval Pathway in the U.S.
  • Figure 21 Global Cardiac Pacemaker Devices Market Share, by Key Players, 2016
  • Figure 22 Global Cardiac Pacemaker Devices Market Size, by Product, 2017-2022 (USD Million)
  • Figure 23 Total Number of Death Due To Cardiovascular Diseases Globally, 2013-2030
  • Figure 24 Global Cardiac Pacemakers Market Size, by Type, 2017-2022 (USD Million)
  • Figure 25 Number of Hospitals in Health System in U.S., 2004-2014
  • Figure 26 Number of Medicare-Certified Ambulatory Surgical Centres in the U.S., 2009-2014
  • Figure 27 Global Facts about Hypertension
  • Figure 28 Global Cardiac Pacemaker Devices Market Size, by Region, 2017-2022 (USD Million)
  • Figure 29 Projected Number of Geriatric Population (Aged 65 Years & Above) in U.S., 2000-2030
  • Figure 30 Total Deaths by Disease Category in U.S.- 2015
  • Figure 31 A Snapshot of High Blood Pressure in the U.S., 2014
  • Figure 32 Ageing Population in Canada
  • Figure 33 Snapshot of Cardiovascular Disease in Europe, 2017
  • Figure 34 The Share of Death by Cause in European Males, 2016
  • Figure 35 The Share of Death by Cause in European Females, 2016
  • Figure 36 Total Number of Deaths from CVD in Major European Countries, 2014-2020
  • Figure 37 Changes in Population Structure in Germany, 1975-2015
  • Figure 38 Total Number of Death by Cause, 2014
  • Figure 39 Percentage of Population Aged 65 Years and Above (% of Total), 2011-2015
  • Figure 40 Incidence of CVD, IHD And Stroke in France, by Sex- 2015
  • Figure 41 Incidence of Cardiovascular Disease in France, by Sex, 2000-2015
  • Figure 42 Share of Aged Popualtion in the Total Population of the U.K., 2005-2045
  • Figure 43 The Share of Death by Cause in the U.K. Women, 2014
  • Figure 44 The Share of Death by Cause in the U.K. Men, 2014
  • Figure 45 Incidence of Cardiovascular Disease in Italy, by Sex, 2000-2015
  • Figure 46 Incidence of CVD, IHD and Stroke in Italy, by Sex, 2015
  • Figure 47 Incidence of CVD, IHD and Stroke in Spain, by Sex, 2015
  • Figure 48 Proportion of Mortality in Japan by Therapeutic Area, 2014
  • Figure 49 Share of Aging Population in Total Chinese Population, 2011-2016 (%)
  • Figure 50 Major Causes of Death in China, 2014
  • Figure 51 Mortality Trends in China, 2010-2014
  • Figure 52 Number of Cases of Coronary Heart Disease (CHD) in India, 2000-2015
  • Figure 53 Principle Causes of Death in Malaysia, 2013-2014
  • Figure 54 Number of Person Aged 60 Years & Above in Latin America, 2015-2030
  • Figure 55 Key GRoWth Strategies Adopted by Key Players -2014-2017
  • Figure 56 Regulatory Approvals Received by Profiled Companies, 2015-2017
  • Figure 57 New Product Launch by Profiled Companies, 2015-2017
  • Figure 58 Medtronic Plc: Financial Overview- 2015-2017
  • Figure 59 Boston Scientific Corporation: Financial Overview- 2014-2016
  • Figure 60 Livanova Plc: Financial Overview- 2015 & 2016
  • Figure 61 Abbott Laboratories: Financial Overview- 2014-2016
Back to Top